The Efficacy and Safety of Atock Dry Syrup With Acute Bronchitis Patients
NCT ID: NCT06411925
Last Updated: 2025-09-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE4
296 participants
INTERVENTIONAL
2023-11-10
2027-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
To Evaluate the Efficacy and Safety of ALC-2203 in Patients With Acute Bronchitis
NCT07061925
Clinical Trial to Evaluate the Safety and Efficacy of "Theobromine Capsule" as an Antitussive in Acute Cougher
NCT01416480
A Clinical Trial to Evaluate the Efficacy and Safety of YMC026 in Respiratory Disease Patients
NCT03334916
Placebo-controlled, Single and Multiple Dose Study in Healthy Volunteers and Refractory Chronic Cough Patients to Assess the Safety, Tolerability, and Pharmacokinetics of Two Formulations of NTX-1175
NCT05628740
Efficacy and Safety of AG2001 in Patients With Acute Bronchitis
NCT07198347
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Atock Dry Syrup
Atock Dry Syrup with placebo patch
Atock Dry syrup (TID) with placebo patch (QD)
tulobuterol patch
Tulobuterol patch with placebo dry syrup
Tulobuterol patch (QD) with placebo dry syrup (TID)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Atock Dry Syrup with placebo patch
Atock Dry syrup (TID) with placebo patch (QD)
Tulobuterol patch with placebo dry syrup
Tulobuterol patch (QD) with placebo dry syrup (TID)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Total Bronchitis Severity Scale excluding sputum(BSSEs) ≥4
3. Wheezing score ≥2
4. Subjects who present symptoms of Acute Bronchitis within 48 hours from screening visit
5. Subject with negative results in HbsAg or HCV Ab test within 6 months from screening visit
Exclusion Criteria
2. Subjects under treatment with corticosteroids, antibiotics medications
3. Subjects with severe hepatic and renal impairment
4. Subjects with a history of drug abuse
5. Subject with positive results in HIV Ab test
6 Months
11 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
SamA Pharmaceutical Co., Ltd
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Soonchunhyang University Seoul Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Hyeon Jong Yang, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SA21901-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.